
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Rab 5A CRISPR/Cas9 KO Plasmid (m) | sc-435445 | 20 µg | $397.00 |
Rab5a encodes the small GTPase Rab 5A, a central regulator of early endosome dynamics that coordinates clathrin-mediated endocytosis, vesicle docking/fusion, and endosomal maturation through effectors such as EEA1 and PI3K signaling nodes. By controlling receptor internalization and trafficking, Rab 5A influences downstream signaling amplitude and duration for pathways including EGFR/MAPK and PI3K/AKT, and contributes to membrane recycling and cargo sorting toward lysosomal degradation. Rab 5A activity is also linked to cytoskeletal remodeling and neurite outgrowth via endosome–actin cross-talk. Dysregulated endocytic trafficking involving Rab5a has been implicated in neurodegeneration-related endosomal defects, altered immune receptor handling, and aberrant growth factor receptor signaling in proliferative disease models.
Rab 5A CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Rab5a gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Rab5a together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Rab5a open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Rab 5A protein expression.
This CRISPR knockout system enables efficient generation of Rab5a-deficient cell models for investigation of Rab 5A signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.